Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Key Factors to Evaluate Before Investing in LITE

Shares of Telecommunications sector company Lumentum moved -7.3% today, and are now trading at a price of $922.24. The Large-Cap stock's daily volume was 4,699,370 compared to its average volume of 6,159,985. The S&P 500 index returned a 1.0% performance.

Lumentum Holdings Inc. manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company is based in San Jose and has 10,562 full time employees. Its market capitalization is $65,847,934,976.

24 analysts are following Lumentum and have set target prices ranging from $455.0 to $1400.0 per share. On average, they have given the company a rating of buy. At today's prices, LITE is trading 1.92% away from its average analyst target price of $904.89 per share.

Over the last year, LITE's share price has increased by 1401.4%, which represents a difference of 1372.5% when compared to the S&P 500. The stock's 52 week high is $1021.0 per share whereas its 52 week low is $60.38. Lumentum's average free cash flow over the last 5 years has been $216.43 Million, but they have been decreasing at an average rate of -32.6%. This may prove a challenge to the long term sustainability of the stock's upwards trend.

          Cash Flow from Operations ($ k) Capital expenditures ($ k)  \

Date Reported
2025 126,300 231,000
2024 24,700 133,000
2023 179,800 128,500
2022 459,300 91,200
2021 738,700 84,800
2020 524,300 86,000

          Free Cash Flow ($ k)  YoY Growth (%)

Date Reported
2025 -104,700 3.32
2024 -108,300 -311.11
2023 51,300 -86.06
2022 368,100 -43.71
2021 653,900 49.19
2020 438,300

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS